Ceritinib is a kinase inhibitor that primarily targets ALK but also inhibits other kinases, such as the insulin-like growth factor 1 receptor (IGF-1R), the insulin receptor (InsR), and ROS1. It blocks ALK autophosphorylation, downstream STAT3 phosphorylation, and proliferation of ALK-dependent cancer cells.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Ceritinib is prescribed for adult patients with metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive, as determined by an FDA-approved test. Always follow the advice of a registered healthcare professional.
Store below 30°C in a cool, dry place away from sunlight and out of children’s reach.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.